No abstract available
MeSH terms
-
Adalimumab
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents / adverse effects*
-
Antirheumatic Agents / therapeutic use
-
Antitubercular Agents / administration & dosage*
-
Arthritis, Rheumatoid / drug therapy*
-
Arthritis, Rheumatoid / immunology
-
Etanercept
-
Humans
-
Immunity, Cellular
-
Immunoglobulin G / adverse effects*
-
Immunoglobulin G / therapeutic use
-
Infliximab
-
Isoniazid / administration & dosage*
-
Receptors, Tumor Necrosis Factor / therapeutic use
-
Tuberculosis / diagnosis
-
Tuberculosis / epidemiology
-
Tuberculosis / etiology*
-
Tuberculosis / prevention & control*
-
Tumor Necrosis Factor-alpha / physiology*
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Antitubercular Agents
-
Immunoglobulin G
-
Receptors, Tumor Necrosis Factor
-
Tumor Necrosis Factor-alpha
-
Infliximab
-
Adalimumab
-
Etanercept
-
Isoniazid